Pular para o conteúdo
Distrofia da retina, genética
ORPHA:71862CID-10 · H35.5DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Visão / ocular
Também conhecida comoOBSOLETE

Um caso de degeneração da retina causada por uma modificação herdada do genoma do indivíduo.

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

Vitreoretinochoroidopatia autossômica dominante (ADVIRC) é um distúrbio que afeta várias partes dos olhos, incluindo o gel transparente que preenche o olho (o vítreo), o tecido sensível à luz que reveste a parte posterior do olho (a retina) e a rede de vasos sanguíneos dentro da retina (a coróide). As anomalias oculares na ADVIRC podem levar a diferentes graus de comprometimento visual, desde redução leve até perda total, embora algumas pessoas com a condição tenham visão normal.

Os sinais e sintomas da ADVIRC variam, mesmo entre membros da mesma família. Muitas pessoas com a condição apresentam microcórnea, na qual a cobertura frontal transparente do olho (córnea) é pequena e anormalmente curvada. A área atrás da córnea também pode ser anormalmente pequena, o que é descrito como câmara anterior rasa. Pessoas com ADVIRC podem desenvolver aumento da pressão nos olhos (glaucoma) ou opacificação da lente do olho (catarata). Além disso, algumas pessoas têm degradação (degeneração) do vítreo ou da coróide.

Uma característica típica da ADVIRC, visível com um exame ocular especial, é uma faixa circular de coloração excessiva (hiperpigmentação) na retina. Essa característica pode ajudar os médicos a diagnosticar o distúrbio. Pessoas com a condição também podem apresentar manchas brancas na retina.

Fonte: MedlinePlus Genetics (NLM/NIH), traduzido
📋
Informacoes curadas por IA — podem conter imprecisoes

Um caso de degeneração da retina causada por uma modificação herdada do genoma do indivíduo.

Pesquisas ativas
30 ensaios
53 total registrados no ClinicalTrials.gov
Em pesquisa
8 moléculas
PEGAPTANIB SODIUM, RANIBIZUMAB, AFLIBERCEPT

O que está sendo pesquisado

8 moléculas em estudo — nenhuma com registro para esta doença
Ver detalhes e fases →
PEGAPTANIB SODIUMRANIBIZUMABAFLIBERCEPTBROLUCIZUMABFARICIMABVORETIGENE NEPARVOVECBEVACIZUMABTRIAMCINOLONE ACETONIDE
Aparecer aqui significa que a molécula foi estudada nesta doença, não que trate. Converse com seu médico.
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H35.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
169 sintomas
🧠
Neurológico
61 sintomas
🦴
Ossos e articulações
41 sintomas
🧬
Pele e cabelo
25 sintomas
📏
Crescimento
24 sintomas
😀
Face
20 sintomas

+ 244 sintomas em outras categorias

Características mais comuns

—
Retinopatia
—
Lesão macular hiperautofluorescente
—
Mancha algodonosa retiniana
—
Anel perifoveal de hiperautofluorescência
—
Astigmatismo misto
—
Reflexo foveal opaco
679sintomas
Sem dados (679)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 679 características clínicas mais associadas, ordenadas por frequência.

RetinopatiaRetinopathy
Lesão macular hiperautofluorescenteHyperautofluorescent macular lesion
Mancha algodonosa retinianaRetinal cotton wool spot
Anel perifoveal de hiperautofluorescênciaPerifoveal ring of hyperautofluorescence
Astigmatismo mistoMixed astigmatism

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa17
Últimos 10 anos1publicações
Pico20091 papers
Linha do tempo
201020202009Hoje · 2026🧪 1994Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

80 genes identificados com associação a esta condição.

Curadoria gene-doença

fontes oficiais
UBAP1L KCNV2 HGSNAT SLC24A1 GNAT1 KCNJ13 REEP6 AGBL5 C1QTNF5 SPATA7 PDE6B CLN3 NR2E3 CRB1 LRATIMPG1STX3
C1QTNF5 GNAT1 GNAT1 HGSNAT KCNV2 REEP6 SLC24A1 SPATA7 PDE6B KCNJ13 AGBL5 NR2E3 CRB1 LRAT
ROM1Rod outer segment membrane protein 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
56.0 TPM
Substância negra
34.4 TPM
Cérebro - Amígdala
24.2 TPM
Hipocampo
23.2 TPM
Cérebro - Hemisfério cerebelar
22.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 7retinitis pigmentosa
HGNC:10254UniProt:Q03395
ADAM9Disintegrin and metalloproteinase domain-containing protein 9Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Collagen degradation
MECANISMO DE DOENÇA

Cone-rod dystrophy 9

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 9cone-rod dystrophy
HGNC:216UniProt:Q13443
OPN1LWLong-wave-sensitive opsin 1Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (3)
OpsinsG alpha (i) signalling eventsThe retinoid cycle in cones (daylight vision)
MECANISMO DE DOENÇA

Colorblindness, partial, protan series

An X-linked color vision defect characterized by a dichromasy in which red and green are confused, with loss of luminance and shift of brightness and hue curves toward the short wave end of the spectrum. Dichromasy is due to the use of only two types of photoreceptors, blue plus red in deuteranopia and blue plus green in protanopia.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Rim - Medula
0.0 TPM
OUTRAS DOENÇAS (4)
red color blindnessblue cone monochromacyX-linked cone dysfunction syndrome with myopiacone-rod dystrophy
HGNC:9936UniProt:P04000
ARHGEF18Rho guanine nucleotide exchange factor 18Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
MECANISMO DE DOENÇA

Retinitis pigmentosa 78

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP78 inheritance is autosomal recessive.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 78retinitis pigmentosa
HGNC:17090UniProt:Q6ZSZ5
RHORhodopsinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (4)
OpsinsG alpha (i) signalling eventsThe canonical retinoid cycle in rods (twilight vision)Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 4

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Frontal Cortex BA9
0.5 TPM
Cerebelo
0.5 TPM
Cérebro - Hemisfério cerebelar
0.5 TPM
Córtex cerebral
0.5 TPM
Testículo
0.2 TPM
OUTRAS DOENÇAS (6)
retinitis pigmentosa 4fundus albipunctatuscongenital stationary night blindness autosomal dominant 1retinitis pigmentosa
HGNC:10012UniProt:P08100
CDH3Cadherin-3Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Adherens junctions interactions
MECANISMO DE DOENÇA

Hypotrichosis congenital with juvenile macular dystrophy

A disorder characterized by congenital hypotrichosis, early hair loss, and severe degenerative changes of the retinal macula that culminate in blindness during the second to third decade of life.

OUTRAS DOENÇAS (2)
congenital hypotrichosis with juvenile macular dystrophyEEM syndrome
HGNC:1762UniProt:P22223
CEP290Centrosomal protein of 290 kDaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Joubert syndrome 5

A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. Joubert syndrome type 5 shares the neurologic and neuroradiologic features of Joubert syndrome together with severe retinal dystrophy and/or progressive renal failure characterized by nephronophthisis.

OUTRAS DOENÇAS (10)
Senior-Loken syndrome 6Leber congenital amaurosis 10Joubert syndrome 5Meckel syndrome, type 4
HGNC:29021UniProt:O15078
ABCA4Retinal-specific phospholipid-transporting ATPase ABCA4Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)ABC-family proteins mediated transport
MECANISMO DE DOENÇA

Stargardt disease 1

An autosomal recessive form of Stargardt disease, a retinal degenerative disease characterized by macular dystrophy, progressive bilateral atrophy of the foveal retinal pigment epithelium, and accumulation of fluorescent flecks around the macula and/or in the central and near-peripheral areas of the retina. STGD1 patients typically lose central vision in their first or second decade of life.

OUTRAS DOENÇAS (8)
severe early-childhood-onset retinal dystrophyretinitis pigmentosa 19cone-rod dystrophy 3ABCA4-related retinopathy
HGNC:34UniProt:P78363
RPGRX-linked retinitis pigmentosa GTPase regulatorDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 3

An X-linked retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. In RP3, affected males have a severe phenotype, and carrier females show a wide spectrum of clinical features ranging from completely asymptomatic to severe retinitis pigmentosa. Heterozygous women can manifest a form of choroidoretinal degeneration which is distinguished from other types by the absence of visual defects in the presence of a brilliant, scintillating, golden-hued, patchy appearance most striking around the macula, called a tapetal-like retinal reflex.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
19.9 TPM
Nervo tibial
17.6 TPM
Tecido adiposo
15.5 TPM
Fallopian Tube
14.7 TPM
Pulmão
14.3 TPM
OUTRAS DOENÇAS (9)
macular degeneration, X-linked atrophicretinitis pigmentosa 3obsolete primary ciliary dyskinesia-retinitis pigmentosa syndromeX-linked cone-rod dystrophy 1
HGNC:10295UniProt:Q92834
AHRAryl hydrocarbon receptorCandidate gene tested inRestrito
VIAS BIOLÓGICAS (1)
Aryl hydrocarbon receptor signalling
MECANISMO DE DOENÇA

Retinitis pigmentosa 85

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP85 is an autosomal recessive form manifesting as early-onset progressive difficulty to adapt in dim light and gradually decreasing visual acuity in both eyes.

OUTRAS DOENÇAS (3)
foveal hypoplasia 3retinitis pigmentosa 85retinitis pigmentosa
HGNC:348UniProt:P35869
TINF2TERF1-interacting nuclear factor 2Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (10)
DNA Damage/Telomere Stress Induced SenescencePackaging Of Telomere EndsMeiotic synapsisInhibition of DNA recombination at telomereTelomere C-strand (Lagging Strand) Synthesis
MECANISMO DE DOENÇA

Dyskeratosis congenita, autosomal dominant, 3

A rare multisystem disorder caused by defective telomere maintenance. It is characterized by progressive bone marrow failure, and the clinical triad of reticulated skin hyperpigmentation, nail dystrophy, and mucosal leukoplakia. Common but variable features include premature graying, aplastic anemia, low platelets, osteoporosis, pulmonary fibrosis, and liver fibrosis among others. Early mortality is often associated with bone marrow failure, infections, fatal pulmonary complications, or malignancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
88.3 TPM
Nervo tibial
85.3 TPM
Artéria tibial
82.2 TPM
Baço
82.0 TPM
Glândula adrenal
81.4 TPM
OUTRAS DOENÇAS (4)
Revesz syndromedyskeratosis congenita, autosomal dominant 3dyskeratosis congenitaHoyeraal-Hreidarsson syndrome
HGNC:11824UniProt:Q9BSI4
BBS2BBSome complex member BBS2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 2

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (4)
Bardet-Biedl syndrome 2retinitis pigmentosa 74retinitis pigmentosaBardet-Biedl syndrome
HGNC:967UniProt:Q9BXC9
IDH3AIsocitrate dehydrogenase [NAD] subunit alpha, mitochondrialCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Citric acid cycle (TCA cycle)Mitochondrial protein degradation
MECANISMO DE DOENÇA

Retinitis pigmentosa 90

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP90 is an autosomal recessive form.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
41.9 TPM
Coração - Átrio
30.6 TPM
Artéria tibial
26.4 TPM
Cérebro - Hemisfério cerebelar
25.3 TPM
Músculo esquelético
25.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 90retinitis pigmentosa
HGNC:5384UniProt:P50213
ARL6ADP-ribosylation factor-like protein 6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Bardet-Biedl syndrome 3

A syndrome characterized by usually severe pigmentary retinopathy, early-onset obesity, polydactyly, hypogenitalism, renal malformation and intellectual disability. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease.

OUTRAS DOENÇAS (5)
retinitis pigmentosa 55Bardet-Biedl syndrome 3retinitis pigmentosaBardet-Biedl syndrome
HGNC:13210UniProt:Q9H0F7
TOPORSE3 ubiquitin-protein ligase ToporsDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
SUMOylation of immune response proteinsSUMOylation of transcription cofactorsSUMOylation of SUMOylation proteins
MECANISMO DE DOENÇA

Retinitis pigmentosa 31

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
31.6 TPM
Ovário
23.5 TPM
Fibroblastos
21.4 TPM
Fallopian Tube
18.9 TPM
Cérebro - Hemisfério cerebelar
18.9 TPM
OUTRAS DOENÇAS (3)
retinitis pigmentosa 31retinitis pigmentosaorofaciodigital syndrome type 6
HGNC:21653UniProt:Q9NS56
PRCDPhotoreceptor disk component PRCDCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 36

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
21.0 TPM
Cérebro - Hemisfério cerebelar
20.5 TPM
Brain Spinal cord cervical c-1
8.0 TPM
Cervix Endocervix
6.6 TPM
Cervix Ectocervix
6.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 36retinitis pigmentosa
HGNC:32528UniProt:Q00LT1
SLC7A14Solute carrier family 7 member 14Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 68

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
21.6 TPM
Cerebelo
15.0 TPM
Pituitária
14.2 TPM
Hipotálamo
9.8 TPM
Brain Spinal cord cervical c-1
9.2 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 68retinitis pigmentosa
HGNC:29326UniProt:Q8TBB6
CACNA1FVoltage-dependent L-type calcium channel subunit alpha-1FDisease-causing germline mutation(s) inRestrito
MECANISMO DE DOENÇA

Night blindness, congenital stationary, 2A

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

OUTRAS DOENÇAS (4)
congenital stationary night blindness 2AX-linked cone-rod dystrophy 3Aland island eye diseasecone-rod dystrophy
HGNC:1393UniProt:O60840
OATOrnithine aminotransferase, mitochondrialCandidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Glutamate and glutamine metabolism
MECANISMO DE DOENÇA

Hyperornithinemia with gyrate atrophy of choroid and retina

A disorder clinically characterized by a triad of progressive chorioretinal degeneration, early cataract formation, and type II muscle fiber atrophy. Characteristic chorioretinal atrophy with progressive constriction of the visual fields leads to blindness at the latest during the sixth decade of life. Patients generally have normal intelligence.

EXPRESSÃO TECIDUAL(Ubíquo)
Intestino delgado
165.3 TPM
Fibroblastos
139.5 TPM
Aorta
118.9 TPM
Artéria tibial
116.9 TPM
Cervix Endocervix
110.6 TPM
OUTRAS DOENÇAS (1)
ornithine aminotransferase deficiency
HGNC:8091UniProt:P04181
PRPF31U4/U6 small nuclear ribonucleoprotein Prp31Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 11

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
81.5 TPM
Útero
81.1 TPM
Fibroblastos
77.6 TPM
Linfócitos
76.5 TPM
Cervix Ectocervix
76.4 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 11retinitis pigmentosa
HGNC:15446UniProt:Q8WWY3
CYP4V2Cytochrome P450 4V2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)Endogenous sterols
MECANISMO DE DOENÇA

Bietti crystalline corneoretinal dystrophy

An autosomal recessive ocular disease characterized by retinal degeneration and marginal corneal dystrophy. Typical features include multiple glistening intraretinal crystals scattered over the fundus, a characteristic degeneration of the retina, and sclerosis of the choroidal vessels, ultimately resulting in progressive night blindness and constriction of the visual field. Most patients have similar crystals at the corneoscleral limbus. Patients develop decreased vision, nyctalopia, and paracentral scotomata between the 2nd and 4th decade of life. Later, they develop peripheral visual field loss and marked visual impairment, usually progressing to legal blindness by the 5th or 6th decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
41.0 TPM
Nervo tibial
30.3 TPM
Glândula adrenal
29.0 TPM
Pituitária
25.4 TPM
Tireoide
23.5 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (1)
Bietti crystalline corneoretinal dystrophy
HGNC:23198UniProt:Q6ZWL3
LRIT3Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1F

An autosomal recessive form of congenital stationary night blindness, a non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cerebelo
1.7 TPM
Cérebro - Hemisfério cerebelar
1.7 TPM
Nervo tibial
1.5 TPM
Testículo
1.2 TPM
Cervix Endocervix
1.0 TPM
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1F
HGNC:24783UniProt:Q3SXY7
GRK1Rhodopsin kinase GRK1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Inactivation, recovery and regulation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, Oguchi type 2

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is associated with fundus discoloration and abnormally slow dark adaptation.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.2 TPM
Testículo
0.6 TPM
Pituitária
0.2 TPM
Cerebelo
0.1 TPM
Cérebro - Hemisfério cerebelar
0.1 TPM
OUTRAS DOENÇAS (2)
Oguchi disease-2Oguchi disease
HGNC:10013UniProt:Q15835
RDH5Retinol dehydrogenase 5Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)RA biosynthesis pathway
MECANISMO DE DOENÇA

Fundus albipunctatus

A form of fleck retina disease characterized by discrete uniform white dots over the entire fundus with greatest density in the mid-periphery and no macular involvement. Night blindness occurs. Inheritance can be autosomal dominant or autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
71.7 TPM
Adipose Visceral Omentum
58.6 TPM
Mama
35.5 TPM
Artéria coronária
30.8 TPM
Fígado
30.8 TPM
OUTRAS DOENÇAS (2)
fundus albipunctatusretinitis punctata albescens
HGNC:9940UniProt:Q92781
CRXCone-rod homeobox proteinCandidate gene tested inModerado
MECANISMO DE DOENÇA

Leber congenital amaurosis 7

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.1 TPM
Fígado
0.1 TPM
Ovário
0.0 TPM
Cerebelo
0.0 TPM
Cérebro - Hemisfério cerebelar
0.0 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 7cone-rod dystrophy 2retinitis pigmentosacone-rod dystrophy
HGNC:2383UniProt:O43186
PCAREPhotoreceptor cilium actin regulatorDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 54

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 54retinitis pigmentosa
HGNC:34383UniProt:A6NGG8
TLCD3BCeramide synthaseCandidate gene tested inModerado
MECANISMO DE DOENÇA

Cone-rod dystrophy 22

An autosomal recessive form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (2)
cone-rod dystrophy 22cone-rod dystrophy
HGNC:25295UniProt:Q71RH2
GNAT2Guanine nucleotide-binding protein G(t) subunit alpha-2Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Ca2+ pathwayG alpha (i) signalling events
MECANISMO DE DOENÇA

Achromatopsia 4

An ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus.

OUTRAS DOENÇAS (3)
achromatopsia 4cone dystrophyachromatopsia
HGNC:4394UniProt:P19087
CNGA3Cyclic nucleotide-gated channel alpha-3Candidate gene tested inTolerante
MECANISMO DE DOENÇA

Achromatopsia 2

An autosomal recessive, ocular stationary disorder due to the absence of functioning cone photoreceptors in the retina. It is characterized by total colorblindness, low visual acuity, photophobia and nystagmus.

OUTRAS DOENÇAS (3)
achromatopsia 2cone-rod dystrophyachromatopsia
HGNC:2150UniProt:Q16281
BEST1Bestrophin-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Stimuli-sensing channels
MECANISMO DE DOENÇA

Macular dystrophy, vitelliform, 2

An autosomal dominant form of macular degeneration that usually begins in childhood or adolescence. VMD2 is characterized by typical 'egg-yolk' macular lesions due to abnormal accumulation of lipofuscin within and beneath the retinal pigment epithelium cells. Progression of the disease leads to destruction of the retinal pigment epithelium and vision loss.

VIAS REACTOME (1)
OUTRAS DOENÇAS (8)
vitelliform macular dystrophy 2retinitis pigmentosa 50autosomal dominant vitreoretinochoroidopathyautosomal recessive bestrophinopathy
HGNC:12703UniProt:O76090
CERKLCeramide kinase-like proteinCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 26

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 26retinitis pigmentosa
HGNC:21699UniProt:Q49MI3
SPATA7Spermatogenesis-associated protein 7Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Leber congenital amaurosis 3

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
61.8 TPM
Cérebro - Hemisfério cerebelar
16.1 TPM
Ovário
14.7 TPM
Pituitária
14.6 TPM
Cerebelo
13.8 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 3severe early-childhood-onset retinal dystrophyLeber congenital amaurosisretinitis pigmentosa
HGNC:20423UniProt:Q9P0W8
PDE6GRetinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 57

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Baço
8.5 TPM
Linfócitos
8.0 TPM
Sangue
2.8 TPM
Testículo
2.5 TPM
Rim - Medula
2.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 57retinitis pigmentosa
HGNC:8789UniProt:P18545
FAM161AProtein FAM161ACandidate gene tested inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 28

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
15.7 TPM
Ovário
10.0 TPM
Pituitária
8.4 TPM
Tireoide
7.0 TPM
Linfócitos
6.5 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 28retinitis pigmentosa
HGNC:25808UniProt:Q3B820
MAKSerine/threonine-protein kinase MAKCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
MECANISMO DE DOENÇA

Retinitis pigmentosa 62

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
15.1 TPM
Sangue
2.7 TPM
Pituitária
1.8 TPM
Fallopian Tube
1.3 TPM
Baço
1.3 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 62retinitis pigmentosa
HGNC:6816UniProt:P20794
IFT140Intraflagellar transport protein 140 homologDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 9 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. SRTD9 is characterized by phalangeal cone-shaped epiphyses, chronic renal disease, nearly constant retinal dystrophy, and mild radiographic abnormality of the proximal femur. Occasional features include short stature, cerebellar ataxia, and hepatic fibrosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
59.8 TPM
Testículo
47.9 TPM
Pituitária
34.4 TPM
Ovário
31.1 TPM
Cervix Endocervix
29.6 TPM
OUTRAS DOENÇAS (8)
retinitis pigmentosa 80cranioectodermal dysplasia 5short-rib thoracic dysplasia 9 with or without polydactylyJeune syndrome
HGNC:29077UniProt:Q96RY7
CLDN19Claudin-19Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
Tight junction interactions
MECANISMO DE DOENÇA

Hypomagnesemia 5, renal, with or without ocular involvement

A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. The renal phenotype is virtually undistinguishable from that of patients with HOMG3.

OUTRAS DOENÇAS (1)
renal hypomagnesemia 5 with ocular involvement
HGNC:2040UniProt:Q8N6F1
CNGA1Cyclic nucleotide-gated channel alpha-1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Retinitis pigmentosa 49

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

OUTRAS DOENÇAS (2)
retinitis pigmentosa 49retinitis pigmentosa
HGNC:2148UniProt:P29973
HKDC1Hexokinase HKDC1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Glycolysis
MECANISMO DE DOENÇA

Retinitis pigmentosa 92

A form of retinitis pigmentosa, a retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. RP92 is an autosomal recessive, mild form with onset of night blindness and vision loss in the third to sixth decades of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
28.3 TPM
Rim - Medula
10.6 TPM
Rim - Córtex
10.1 TPM
Nervo tibial
9.8 TPM
Tireoide
5.6 TPM
OUTRAS DOENÇAS (1)
retinitis pigmentosa 92
HGNC:HGNC:23302UniProt:Q2TB90
RS1RetinoschisinCandidate gene tested inAltamente restrito
MECANISMO DE DOENÇA

Retinoschisis juvenile X-linked 1

A vitreo-retinal dystrophy characterized by macular pathology and by splitting of the superficial layer of the retina. Macular changes are present in almost all cases. In the fundi, radially oriented intraretinal foveomacular cysts are seen in a spoke-wheel configuration, with the absence of foveal reflex in most cases. In addition, approximately half of cases have bilateral peripheral retinoschisis in the inferotemporal part of the retina. Aside from the typical fundus appearance, strabismus, nystagmus, axial hyperopia, defective color vision and foveal ectopy can be present. The most important complications are vitreous hemorrhage, retinal detachment, and neovascular glaucoma.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pulmão
2.2 TPM
Brain Frontal Cortex BA9
1.4 TPM
Córtex cerebral
1.2 TPM
Brain Anterior cingulate cortex BA24
1.0 TPM
Brain Caudate basal ganglia
1.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
X-linked retinoschisis
HGNC:10457UniProt:O15537
RPE65Retinoid isomerohydrolaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
The canonical retinoid cycle in rods (twilight vision)
MECANISMO DE DOENÇA

Leber congenital amaurosis 2

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Substância negra
4.6 TPM
Hipotálamo
2.6 TPM
Brain Spinal cord cervical c-1
0.8 TPM
Próstata
0.6 TPM
Hipocampo
0.5 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 20Leber congenital amaurosis 2retinitis pigmentosa 87 with choroidal involvementRPE65-related recessive retinopathy
HGNC:10294UniProt:Q16518
MFSD8Major facilitator superfamily domain-containing protein 8Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Ceroid lipofuscinosis, neuronal, 7

A form of neuronal ceroid lipofuscinosis with onset in early childhood. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 7 comprise mixed combinations of granular, curvilinear, fingerprint, and rectilinear profiles.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
20.7 TPM
Ovário
16.8 TPM
Cervix Endocervix
16.7 TPM
Cerebelo
16.7 TPM
Útero
16.4 TPM
OUTRAS DOENÇAS (3)
macular dystrophy with central cone involvementneuronal ceroid lipofuscinosis 7cone-rod dystrophy
HGNC:28486UniProt:Q8NHS3
SAGS-arrestinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Inactivation, recovery and regulation of the phototransduction cascadeActivation of the phototransduction cascade
MECANISMO DE DOENÇA

Night blindness, congenital stationary, Oguchi type 1

A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is an autosomal recessive form associated with fundus discoloration and abnormally slow dark adaptation.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
7.2 TPM
Brain Nucleus accumbens basal ganglia
4.1 TPM
Brain Caudate basal ganglia
1.2 TPM
Brain Putamen basal ganglia
0.7 TPM
Cervix Endocervix
0.4 TPM
OUTRAS DOENÇAS (5)
Oguchi disease-1retinitis pigmentosa 47retinitis pigmentosa 96retinitis pigmentosa
HGNC:10521UniProt:P10523
RP1L1Retinitis pigmentosa 1-like 1 proteinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Occult macular dystrophy

An inherited macular dystrophy characterized by progressive loss of macular function but normal ophthalmoscopic appearance. It is typically characterized by a central cone dysfunction leading to a loss of vision despite normal ophthalmoscopic appearance, normal fluorescein angiography, and normal full-field electroretinogram (ERGs), but the amplitudes of the focal macular ERGs and multifocal ERGs are significantly reduced at the central retina.

EXPRESSÃO TECIDUAL(Baixa expressão)
Skin Sun Exposed Lower leg
0.6 TPM
Skin Not Sun Exposed Suprapubic
0.5 TPM
Pituitária
0.4 TPM
Testículo
0.3 TPM
Vagina
0.3 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (3)
occult macular dystrophyretinitis pigmentosa 88retinitis pigmentosa
HGNC:15946UniProt:Q8IWN7
PRPF3U4/U6 small nuclear ribonucleoprotein Prp3Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
mRNA Splicing - Major Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 18

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
61.9 TPM
Tireoide
59.6 TPM
Nervo tibial
54.5 TPM
Cervix Endocervix
52.6 TPM
Cervix Ectocervix
50.6 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 18retinitis pigmentosa
HGNC:17348UniProt:O43395
FBLN5Fibulin-5Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (2)
Molecules associated with elastic fibresElastic fibre formation
MECANISMO DE DOENÇA

Charcot-Marie-Tooth disease, demyelinating, type 1H

An autosomal dominant demyelinating form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1H is characterized by peripheral sensorimotor neuropathy with onset usually in adulthood. Affected individuals present with foot deformities, upper or lower limb sensory disturbances, and motor deficits, mainly impaired gait. Rare patients may have hyperelastic skin or develop age-related macular degeneration.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
795.1 TPM
Fibroblastos
292.3 TPM
Artéria coronária
255.6 TPM
Útero
195.1 TPM
Artéria tibial
192.2 TPM
OUTRAS DOENÇAS (7)
macular degeneration, age-related, 3cutis laxa, autosomal recessive, type 1Acutis laxa, autosomal dominant 2Charcot-Marie-Tooth disease, demyelinating, IIA 1H
HGNC:3602UniProt:Q9UBX5
SNRNP200U5 small nuclear ribonucleoprotein 200 kDa helicaseCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (3)
mRNA Splicing - Major PathwayDengue Virus-Host InteractionsmRNA Splicing - Minor Pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 33

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
153.3 TPM
Ovário
132.5 TPM
Útero
119.1 TPM
Cervix Endocervix
112.7 TPM
Cérebro - Hemisfério cerebelar
109.0 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 33retinitis pigmentosa
HGNC:30859UniProt:O75643
LCA5LebercilinCandidate gene tested inTolerante
MECANISMO DE DOENÇA

Leber congenital amaurosis 5

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
8.4 TPM
Cervix Endocervix
8.0 TPM
Fallopian Tube
7.9 TPM
Útero
7.7 TPM
Ovário
7.4 TPM
OUTRAS DOENÇAS (3)
Leber congenital amaurosis 5severe early-childhood-onset retinal dystrophyLeber congenital amaurosis
HGNC:31923UniProt:Q86VQ0
PROM1Prominin-1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Developmental Lineage of Pancreatic Ductal Cells
MECANISMO DE DOENÇA

Retinitis pigmentosa 41

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
69.0 TPM
Rim - Medula
33.8 TPM
Cólon transverso
13.8 TPM
Intestino delgado
11.7 TPM
Testículo
8.3 TPM
OUTRAS DOENÇAS (7)
Stargardt disease 4retinitis pigmentosa 41retinal macular dystrophy type 2cone-rod dystrophy 12
HGNC:9454UniProt:O43490
PRPH2Peripherin-2Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 7

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
9.3 TPM
Ovário
6.8 TPM
Cervix Ectocervix
5.7 TPM
Pituitária
5.3 TPM
Músculo esquelético
5.0 TPM
OUTRAS DOENÇAS (13)
retinitis pigmentosa 7vitelliform macular dystrophy 3fundus albipunctatuschoroidal dystrophy, central areolar 2
HGNC:9942UniProt:P23942
BBS1BBSome complex member BBS1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
OUTRAS DOENÇAS (3)
Bardet-Biedl syndrome 1retinitis pigmentosaBardet-Biedl syndrome
HGNC:966UniProt:Q8NFJ9
MERTKTyrosine-protein kinase MerCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Cell surface interactions at the vascular wallDengue Virus Attachment and Entry
MECANISMO DE DOENÇA

Retinitis pigmentosa 38

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
52.4 TPM
Artéria tibial
46.6 TPM
Baço
37.9 TPM
Aorta
33.9 TPM
Testículo
31.7 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 38retinitis pigmentosa
HGNC:7027UniProt:Q12866
KIZCentrosomal protein kizunaDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 69

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
60.4 TPM
Cervix Endocervix
50.2 TPM
Cervix Ectocervix
38.4 TPM
Ovário
36.5 TPM
Bladder
35.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
retinitis pigmentosa 69retinitis pigmentosa
HGNC:15865UniProt:Q2M2Z5
CLEC3BTetranectinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Platelet degranulation
MECANISMO DE DOENÇA

Macular dystrophy, retinal, 4

An autosomal dominant retinal disease characterized by late-onset macular degeneration, with multiple drusen-like deposits, macular geographic atrophy, and choroidal neovascularization. Patients also exhibit extensive retinal dysfunction with impaired rod function.

VIAS REACTOME (1)
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
macular dystrophy, retinal, 4
HGNC:HGNC:11891UniProt:P05452
TUBGCP6Gamma-tubulin complex component 6Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Recruitment of mitotic centrosome proteins and complexesRecruitment of NuMA to mitotic centrosomes
MECANISMO DE DOENÇA

Microcephaly and chorioretinopathy, autosomal recessive, 1

A syndrome characterized by microcephaly, cognitive impairment, underdeveloped retina and choroid, and epilepsy in some patients. The more anterior parts of the retina, near the periphery and pars plana, have a grayish hue and diminutive vasculature similar to retinopathy of prematurity. Visual impairment becomes evident during the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
124.7 TPM
Cérebro - Hemisfério cerebelar
109.4 TPM
Tireoide
83.5 TPM
Pituitária
80.3 TPM
Cervix Endocervix
66.9 TPM
OUTRAS DOENÇAS (1)
microcephaly and chorioretinopathy 1
HGNC:18127UniProt:Q96RT7
ARL2BPADP-ribosylation factor-like protein 2-binding proteinDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
MECANISMO DE DOENÇA

Retinitis pigmentosa 82 with or without situs inversus

An autosomal recessive disorder characterized by variable association of retinitis pigmentosa with situs inversus. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. Situs inversus is a congenital abnormality in which organs in the thorax and the abdomen are opposite to their normal positions due to lateral transposition.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
retinitis pigmentosa with or without situs inversusretinitis pigmentosa
HGNC:17146UniProt:Q9Y2Y0
IMPDH1Inosine-5'-monophosphate dehydrogenase 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
Purine ribonucleoside monophosphate biosynthesisAzathioprine ADMEPotential therapeutics for SARS
MECANISMO DE DOENÇA

Retinitis pigmentosa 10

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
172.5 TPM
Baço
95.6 TPM
Fibroblastos
82.8 TPM
Adipose Visceral Omentum
79.9 TPM
Tecido adiposo
66.9 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 11retinitis pigmentosa 10retinitis pigmentosaLeber congenital amaurosis
HGNC:6052UniProt:P20839
KIF11Kinesin-like protein KIF11Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
KinesinsCOPI-dependent Golgi-to-ER retrograde trafficMHC class II antigen presentation
MECANISMO DE DOENÇA

Microcephaly with or without chorioretinopathy, lymphedema, or impaired intellectual development

An autosomal dominant disorder that involves an overlapping but variable spectrum of central nervous system and ocular developmental anomalies. Microcephaly ranges from mild to severe and is often associated with mild to moderate developmental delay and a characteristic facial phenotype with upslanting palpebral fissures, broad nose with rounded tip, long philtrum with thin upper lip, prominent chin, and prominent ears. Chorioretinopathy is the most common eye abnormality, but retinal folds, microphthalmia, and myopic and hypermetropic astigmatism have also been reported, and some individuals have no overt ocular phenotype. Congenital lymphedema, when present, is typically confined to the dorsa of the feet, and lymphoscintigraphy reveals the absence of radioactive isotope uptake from the webspaces between the toes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
53.2 TPM
Testículo
18.2 TPM
Fibroblastos
17.5 TPM
Esôfago - Mucosa
10.3 TPM
Skin Sun Exposed Lower leg
4.6 TPM
OUTRAS DOENÇAS (1)
microcephaly with or without chorioretinopathy, lymphedema, or intellectual disability
HGNC:6388UniProt:P52732
PDE6ARod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alphaDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (1)
Ca2+ pathway
MECANISMO DE DOENÇA

Retinitis pigmentosa 43

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
4.6 TPM
Pituitária
3.1 TPM
Esôfago - Mucosa
1.5 TPM
Cólon transverso
1.1 TPM
Glândula adrenal
0.8 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 43retinitis pigmentosa
HGNC:8785UniProt:P16499
RPGRIP1X-linked retinitis pigmentosa GTPase regulator-interacting protein 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateAnchoring of the basal body to the plasma membrane
MECANISMO DE DOENÇA

Leber congenital amaurosis 6

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
40.1 TPM
Baço
1.2 TPM
Intestino delgado
0.7 TPM
Sangue
0.6 TPM
Mama
0.5 TPM
OUTRAS DOENÇAS (5)
Leber congenital amaurosis 6cone-rod dystrophy 13Leber congenital amaurosisMeckel syndrome
HGNC:13436UniProt:Q96KN7
CFHComplement factor HCandidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (1)
Regulation of Complement cascade
MECANISMO DE DOENÇA

Basal laminar drusen

Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch membrane. Basal laminar drusen refers to an early adult-onset drusen phenotype that shows a pattern of uniform small, slightly raised yellow subretinal nodules randomly scattered in the macula. In later stages, these drusen often become more numerous, with clustered groups of drusen scattered throughout the retina. In time these small basal laminar drusen may expand and ultimately lead to a serous pigment epithelial detachment of the macula that may result in vision loss.

OUTRAS DOENÇAS (10)
complement factor H deficiencybasal laminar drusendense deposit diseaseDoyne honeycomb retinal dystrophy
HGNC:4883UniProt:P08603
LRATLecithin retinol acyltransferaseCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
The canonical retinoid cycle in rods (twilight vision)Retinoid metabolism and transport
MECANISMO DE DOENÇA

Leber congenital amaurosis 14

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
3.3 TPM
Brain Spinal cord cervical c-1
3.1 TPM
Tireoide
2.8 TPM
Cólon sigmoide
2.4 TPM
Nervo tibial
2.2 TPM
OUTRAS DOENÇAS (4)
Leber congenital amaurosis 14severe early-childhood-onset retinal dystrophyretinitis pigmentosaLeber congenital amaurosis
HGNC:6685UniProt:O95237
TTC8Tetratricopeptide repeat protein 8Candidate gene tested inTolerante
VIAS BIOLÓGICAS (1)
BBSome-mediated cargo-targeting to cilium
MECANISMO DE DOENÇA

Retinitis pigmentosa 51

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
40.7 TPM
Pituitária
30.5 TPM
Testículo
20.5 TPM
Glândula adrenal
19.6 TPM
Tireoide
18.3 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 51Bardet-Biedl syndrome 8retinitis pigmentosaBardet-Biedl syndrome
HGNC:20087UniProt:Q8TAM2
RAB28Ras-related protein Rab-28Candidate gene tested inTolerante
MECANISMO DE DOENÇA

Cone-rod dystrophy 18

A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
44.8 TPM
Nervo tibial
36.4 TPM
Pituitária
35.5 TPM
Fallopian Tube
33.6 TPM
Cervix Endocervix
32.0 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
cone-rod dystrophy 18cone-rod dystrophy
HGNC:9768UniProt:P51157
AIPL1Aryl-hydrocarbon-interacting protein-like 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Leber congenital amaurosis 4

A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus.

OUTRAS DOENÇAS (4)
Leber congenital amaurosis 4AIPL1-related retinopathycone-rod dystrophyLeber congenital amaurosis
HGNC:359UniProt:Q9NZN9
RAX2Retina and anterior neural fold homeobox protein 2Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Macular degeneration, age-related, 6

A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.

EXPRESSÃO TECIDUAL(Baixa expressão)
Pituitária
1.9 TPM
Fallopian Tube
0.9 TPM
Útero
0.7 TPM
Cervix Endocervix
0.1 TPM
Testículo
0.1 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 95cone-rod dystrophy 11age related macular degeneration 6cone-rod dystrophy
HGNC:18286UniProt:Q96IS3
GPR179Probable G-protein coupled receptor 179Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Night blindness, congenital stationary, 1E

An autosomal recessive, non-progressive retinal disorder characterized by impaired night vision, absence of the electroretinogram (ERG) b-wave, and variable degrees of involvement of other visual functions. Affected individuals have an ERG waveform that lacks the b-wave because of failure to transmit the photoreceptor signal through the retinal depolarizing bipolar cells.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cérebro - Hemisfério cerebelar
2.5 TPM
Cerebelo
2.5 TPM
Córtex cerebral
1.5 TPM
Brain Frontal Cortex BA9
1.4 TPM
Brain Nucleus accumbens basal ganglia
1.3 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (1)
congenital stationary night blindness 1E
HGNC:31371UniProt:Q6PRD1
IMPG2Interphotoreceptor matrix proteoglycan 2Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Retinitis pigmentosa 56

A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.

EXPRESSÃO TECIDUAL(Baixa expressão)
Fallopian Tube
0.8 TPM
Rim - Medula
0.7 TPM
Artéria coronária
0.5 TPM
Nervo tibial
0.4 TPM
Baço
0.4 TPM
OUTRAS DOENÇAS (4)
retinitis pigmentosa 56vitelliform macular dystrophy 5retinitis pigmentosaadult-onset foveomacular vitelliform dystrophy
HGNC:18362UniProt:Q9BZV3
RCBTB1RCC1 and BTB domain-containing protein 1Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Retinal dystrophy with or without extraocular anomalies

An autosomal recessive disease characterized by progressive retinal dystrophy, chorioretinal macular atrophy, reduced cone and rod responses on ERG, and decrease visual acuity. Extraocular anomalies are variably present in some patients and include pulmonary fibrosis, sensorineural hearing loss, and endocrine features such as goiter and primary ovarian insufficiency.

EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
77.1 TPM
Brain Spinal cord cervical c-1
37.8 TPM
Glândula adrenal
33.7 TPM
Útero
30.5 TPM
Substância negra
29.0 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
RCBTB1-related retinopathyreticular dystrophy of the retinal pigment epithelium
HGNC:18243UniProt:Q8NDN9
PAX6Paired box protein Pax-6Candidate gene tested inAltamente restrito
VIAS BIOLÓGICAS (5)
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)Regulation of gene expression in beta cellsActivation of anterior HOX genes in hindbrain development during early embryogenesisFormation of the anterior neural plateSynthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
MECANISMO DE DOENÇA

Aniridia 1

A congenital, bilateral, panocular disorder characterized by complete absence of the iris or extreme iris hypoplasia. Aniridia is not just an isolated defect in iris development but it is associated with macular and optic nerve hypoplasia, cataract, corneal changes, nystagmus. Visual acuity is generally low but is unrelated to the degree of iris hypoplasia. Glaucoma is a secondary problem causing additional visual loss over time.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
40.8 TPM
Cerebelo
36.9 TPM
Córtex cerebral
3.5 TPM
Brain Caudate basal ganglia
3.4 TPM
Brain Anterior cingulate cortex BA24
3.3 TPM
OUTRAS DOENÇAS (17)
coloboma, ocular, autosomal dominantisolated optic nerve hypoplasiaautosomal dominant keratitisfoveal hypoplasia 1
HGNC:8620UniProt:P26367
IFT172Intraflagellar transport protein 172 homologCandidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateIntraflagellar transport
MECANISMO DE DOENÇA

Short-rib thoracic dysplasia 10 with or without polydactyly

A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
57.3 TPM
Pituitária
51.2 TPM
Ovário
41.6 TPM
Tireoide
30.7 TPM
Cerebelo
30.2 TPM
OUTRAS DOENÇAS (7)
retinitis pigmentosa 71Bardet-Biedl syndrome 20short-rib thoracic dysplasia 10 with or without polydactylyshort-rib thoracic dysplasia 9 with or without polydactyly
HGNC:30391UniProt:Q9UG01
TREX1Three-prime repair exonuclease 1Candidate gene tested inTolerante
VIAS BIOLÓGICAS (2)
IRF3-mediated induction of type I IFNRegulation by TREX1
MECANISMO DE DOENÇA

Aicardi-Goutieres syndrome 1

A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
80.6 TPM
Baço
45.2 TPM
Skin Sun Exposed Lower leg
42.6 TPM
Skin Not Sun Exposed Suprapubic
42.3 TPM
Pituitária
42.0 TPM
OUTRAS DOENÇAS (6)
retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationschilblain lupus 1Aicardi-Goutieres syndrome 1Aicardi-Goutieres syndrome
HGNC:12269UniProt:Q9NSU2
RBP4Retinol-binding protein 4Disease-causing germline mutation(s) inRestrito
VIAS BIOLÓGICAS (1)
Retinoid metabolism disease events
MECANISMO DE DOENÇA

Retinal dystrophy, iris coloboma, and comedogenic acne syndrome

A disease characterized by retinal degeneration, ocular colobomas involving both the anterior and posterior segment, impaired night vision and loss of visual acuity. Additional characteristic features include developmental abnormalities and severe acne.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
4153.5 TPM
Tecido adiposo
554.2 TPM
Pituitária
376.5 TPM
Adipose Visceral Omentum
289.3 TPM
Mama
162.8 TPM
OUTRAS DOENÇAS (3)
progressive retinal dystrophy due to retinol transport defectmicrophthalmia, isolated, with coloboma 10microphthalmia, isolated, with coloboma
HGNC:9922UniProt:P02753
TUBB4BTubulin beta-4B chainDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (10)
HCMV Early EventsPKR-mediated signalingGap junction assemblyAggrephagyAssembly and cell surface presentation of NMDA receptors
MECANISMO DE DOENÇA

Leber congenital amaurosis with early-onset deafness

An autosomal dominant disease characterized by severe retinal degeneration and sensorineural hearing loss. Symptoms occur within the first decade of life. Onset at birth is observed in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
1825.9 TPM
Fibroblastos
703.0 TPM
Esôfago - Mucosa
500.6 TPM
Skin Not Sun Exposed Suprapubic
374.1 TPM
Linfócitos
355.3 TPM
OUTRAS DOENÇAS (2)
Leber congenital amaurosis with early-onset deafnessLeber congenital amaurosis
HGNC:20771UniProt:P68371
RP1Oxygen-regulated protein 1Candidate gene tested inTolerante
MECANISMO DE DOENÇA

Skin creases, congenital symmetric circumferential, 2

An autosomal dominant disease characterized by multiple, symmetric, circumferential rings of folded skin, affecting primarily the limbs. Affected individuals also exhibit intellectual disability, cleft palate, and dysmorphic features.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
0.9 TPM
Pulmão
0.8 TPM
Rim - Medula
0.3 TPM
Fallopian Tube
0.3 TPM
Estômago
0.2 TPM
OUTRAS DOENÇAS (2)
retinitis pigmentosa 1retinitis pigmentosa
HGNC:10263UniProt:P56715
ACO2Aconitate hydratase, mitochondrialDisease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (3)
Citric acid cycle (TCA cycle)Maturation of TCA enzymes and regulation of TCA cycleMitochondrial protein degradation
MECANISMO DE DOENÇA

Infantile cerebellar-retinal degeneration

A severe autosomal recessive neurodegenerative disorder characterized by onset between ages 2 and 6 months of truncal hypotonia, athetosis, seizures, and ophthalmologic abnormalities, particularly optic atrophy and retinal degeneration. Affected individuals show profound psychomotor retardation, with only some achieving rolling, sitting, or recognition of family. Brain MRI shows progressive cerebral and cerebellar degeneration.

OUTRAS DOENÇAS (3)
infantile cerebellar-retinal degenerationoptic atrophy 9obsolete autosomal recessive optic atrophy
HGNC:118UniProt:Q99798
CFAP418Cilia- and flagella-associated protein 418Disease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Cone-rod dystrophy 16

An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa, due to cone photoreceptors degenerating at a higher rate than rod photoreceptors.

OUTRAS DOENÇAS (5)
cone-rod dystrophy 16bardet-biedl syndrome 21cone-rod dystrophyretinitis pigmentosa
HGNC:27232UniProt:Q96NL8
RLBP1Retinaldehyde-binding protein 1Disease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)The retinoid cycle in cones (daylight vision)Defective visual phototransduction due to RDH5 loss of function
MECANISMO DE DOENÇA

Bothnia retinal dystrophy

A type of retinitis punctata albescens. Affected individuals show night blindness from early childhood with features consistent with retinitis punctata albescens and macular degeneration.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Caudate basal ganglia
11.3 TPM
Córtex cerebral
11.2 TPM
Brain Putamen basal ganglia
10.5 TPM
Brain Frontal Cortex BA9
9.5 TPM
Brain Anterior cingulate cortex BA24
7.6 TPM
OUTRAS DOENÇAS (5)
fundus albipunctatusNewfoundland cone-rod dystrophyBothnia retinal dystrophyretinitis pigmentosa
HGNC:10024UniProt:P12271
FBN2Fibrillin-2Disease-causing germline mutation(s) inAltamente restrito
VIAS BIOLÓGICAS (1)
Elastic fibre formation
MECANISMO DE DOENÇA

Contractural arachnodactyly, congenital

An autosomal dominant connective tissue disorder characterized by contractures, arachnodactyly, scoliosis, and crumpled ears.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fibroblastos
126.7 TPM
Testículo
6.0 TPM
Glândula adrenal
5.0 TPM
Esôfago - Muscular
2.9 TPM
Coração - Ventrículo esquerdo
2.7 TPM
OUTRAS DOENÇAS (2)
macular degeneration, early-onsetcongenital contractural arachnodactyly
HGNC:3604UniProt:P35556
USH2AUsherinDisease-causing germline mutation(s) inTolerante
MECANISMO DE DOENÇA

Usher syndrome 2A

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.2 TPM
Fígado
0.8 TPM
Cérebro - Hemisfério cerebelar
0.2 TPM
Cerebelo
0.2 TPM
Coração - Átrio
0.2 TPM
OUTRAS DOENÇAS (5)
retinitis pigmentosa 39Usher syndrome type 2AUsher syndromeretinitis pigmentosa
HGNC:12601UniProt:O75445

Medicamentos e terapias

PEGAPTANIB SODIUMPhase 4

Mecanismo: Vascular endothelial growth factor A antagonist

RANIBIZUMABPhase 4

Mecanismo: Vascular endothelial growth factor A inhibitor

AFLIBERCEPTPhase 4

Mecanismo: Placenta growth factor inhibitor

BROLUCIZUMABPhase 4

Mecanismo: Vascular endothelial growth factor A inhibitor

FARICIMABPhase 4

Mecanismo: Angiopoietin-2 inhibitor

VORETIGENE NEPARVOVECPhase 4

Mecanismo: Retinoid isomerohydrolase exogenous gene

BEVACIZUMABPhase 3

Mecanismo: Vascular endothelial growth factor A inhibitor

TRIAMCINOLONE ACETONIDEPhase 3

Mecanismo: Glucocorticoid receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

406 variantes patogênicas registradas no ClinVar.

🧬 ROM1: GRCh37/hg19 11q12.1-13.3(chr11:56895955-69295402)x3 ()
🧬 ROM1: GRCh37/hg19 11p11.12-q13.1(chr11:50398499-63924462)x3 ()
🧬 ROM1: GRCh37/hg19 11q12.2-13.5(chr11:59923608-76272324)x3 ()
🧬 ROM1: GRCh37/hg19 11p13-q25(chr11:32799481-134938470)x3 ()
🧬 ROM1: NM_000327.4(ROM1):c.941G>A (p.Gly314Glu) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

125 vias biológicas associadas aos genes desta condição.

Collagen degradation The retinoid cycle in cones (daylight vision) G alpha (i) signalling events Opsins Defective visual phototransduction due to OPN1LW loss of function NRAGE signals death through JNK TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) G alpha (12/13) signalling events RHOA GTPase cycle RAC1 GTPase cycle The canonical retinoid cycle in rods (twilight vision) Activation of the phototransduction cascade Inactivation, recovery and regulation of the phototransduction cascade VxPx cargo-targeting to cilium Adherens junctions interactions Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane Neutrophil degranulation AURKA Activation by TPX2 ABC-family proteins mediated transport Defective visual phototransduction due to ABCA4 loss of function RPGRIP1L RAB8A,10,13,14 exchange GDP for GTP PPARA activates gene expression Phase I - Functionalization of compounds Endogenous sterols Xenobiotics Aryl hydrocarbon receptor signalling Recognition and association of DNA glycosylase with site containing an affected pyrimidine Cleavage of the damaged pyrimidine Recognition and association of DNA glycosylase with site containing an affected purine Cleavage of the damaged purine Meiotic synapsis Packaging Of Telomere Ends Telomere Extension By Telomerase Polymerase switching on the C-strand of the telomere Processive synthesis on the C-strand of the telomere Telomere C-strand (Lagging Strand) Synthesis Telomere C-strand synthesis initiation Removal of the Flap Intermediate from the C-strand DNA Damage/Telomere Stress Induced Senescence Inhibition of DNA recombination at telomere BBSome-mediated cargo-targeting to cilium Citric acid cycle (TCA cycle) Mitochondrial protein degradation SUMOylation of transcription cofactors SUMOylation of SUMOylation proteins SUMOylation of immune response proteins Glutamate and glutamine metabolism mRNA Splicing - Major Pathway RA biosynthesis pathway Defective visual phototransduction due to RDH5 loss of function Ca2+ pathway Stimuli-sensing channels NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux Diseases of branched-chain amino acid catabolism PTEN Regulation Regulation of PTEN gene transcription FCERI mediated NF-kB activation TP53 Regulates Metabolic Genes Stabilization of p53 Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN) Regulation of TP53 Activity through Phosphorylation TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway Hedgehog 'off' state Intraflagellar transport Tight junction interactions Glycolysis OCT2 mediates tubular secretion of organic cations in the kidney OCT2 mediates tubular uptake of organic cations in the kidney SLC5A1 cotransports Glc,Gal with Na+ from extracellular region to cytosol Elastic fibre formation Molecules associated with elastic fibres mRNA Splicing - Minor Pathway Dengue Virus-Host Interactions Developmental Lineage of Pancreatic Ductal Cells Cell surface interactions at the vascular wall Dengue Virus Attachment and Entry Transphosphorylation of pLIMK1 Platelet degranulation Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane Purine ribonucleoside monophosphate biosynthesis Potential therapeutics for SARS Azathioprine ADME MHC class II antigen presentation COPI-dependent Golgi-to-ER retrograde traffic Kinesins Regulation of Complement cascade Retinoid metabolism and transport Defective visual phototransduction due to LRAT loss of function Regulation of gene expression in beta cells Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) Activation of anterior HOX genes in hindbrain development during early embryogenesis Formation of the anterior neural plate Regulation by TREX1 IRF3-mediated induction of type I IFN Retinoid metabolism disease events Defective visual phototransduction due to STRA6 loss of function Translocation of SLC2A4 (GLUT4) to the plasma membrane Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane Gap junction assembly Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand Prefoldin mediated transfer of substrate to CCT/TriC Formation of tubulin folding intermediates by CCT/TriC Post-chaperonin tubulin folding pathway Recycling pathway of L1 Cargo trafficking to the periciliary membrane RHO GTPases activate IQGAPs RHO GTPases Activate Formins COPI-mediated anterograde transport COPI-independent Golgi-to-ER retrograde traffic Mitotic Prometaphase The role of GTSE1 in G2/M progression after G2 checkpoint Carboxyterminal post-translational modifications of tubulin RP105:MD1 Mitochondrial protein import Maturation of TCA enzymes and regulation of TCA cycle Degradation of the extracellular matrix

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
✓Aprovado6
3Fase 37
2Fase 212
1Fase 16
·Pré-clínico30
Medicamentos catalogadosEnsaios clínicos· 8 medicamentos · 53 ensaios
✓ Aprovados — podem ser usados hoje
PEGAPTANIB SODIUMRANIBIZUMABAFLIBERCEPTBROLUCIZUMABFARICIMABVORETIGENE NEPARVOVEC
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Distrofia da retina, genética

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 19 países. O ponto verde marca onde há vaga agora.

🟢 Recrutando agora

15 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT05626920 · Disulfiram for Treatment of Retinal DegenerationRecrutando
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT07548944 · Observational Study to Investigate the Short-term Effects of…Recrutando
🇩🇪 Alemanha
NCT07502664 · Development and Evaluation of Functional Visual Field and Na…Recrutando
🇺🇸 Estados Unidos
NCT07656753 · Safety and Efficacy Study of PUMCH-E111 Injection in Subject…Recrutando
EARLY_PHASE1🇨🇳 China
NCT07807111 · Open-Label Study to Evaluate the Safety, Tolerability, and E…Recrutando
PHASE1, PHASE2🇧🇪 Bélgica · 🇫🇷 França · 🇮🇪 Irlanda
NCT07085533 · Natural History Study of Inherited Retinal DiseasesRecrutando
🇨🇳 China
NCT07063030 · A Study of LX107 Gene Therapy in AIPL1-IRD PatientsRecrutando
EARLY_PHASE1🇨🇳 China
NCT06395285 · Evaluating the Safety and Tolerability of Orally Administere…Recrutando
PHASE1🇦🇺 Austrália · 🇨🇳 China · 🇺🇸 Estados Unidos
NCT06319872 · The Effects of Disulfiram (Antabuse®) on Visual Acuity in Pa…Recrutando
PHASE1🇺🇸 Estados Unidos
NCT06375239 · Observational Study to Assess Endpoint Operational Feasibili…Recrutando
🇺🇸 Estados Unidos
NCT05976139 · Micropulsed Laser in Patients With Macular Oedema in Retinal…Recrutando
NA🇮🇹 Itália
NCT05294978 · EyeConic: Qualification for Cone-OptogeneticsRecrutando
🇨🇳 China · 🇩🇪 Alemanha · Hungary +4
NCT03011541 · Stem Cell Ophthalmology Treatment Study IIRecrutando
NA🇦🇹 Áustria · United Arab Emirates · 🇺🇸 Estados Unidos
NCT02014389 · Evaluation of Objective Perimetry Using Chromatic Multifocal…Recrutando
🇮🇱 Israel
NCT00001373 · Familial Mediterranean Fever and Related Disorders: Genetics…Recrutando
🇺🇸 Estados Unidos

Outros ensaios clínicos

53 ensaios clínicos encontrados, 30 ativos.

Distribuição por fase
NCT07082855 · A Multicenter, Randomized, Double-Blind, Controlled Clinical…Em breve
PHASE3🇨🇳 China
NCT06908161 · Functional Assessments in Vision ImpairmentEm breve
🇦🇺 Austrália
NCT06852963 · A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study…Ativo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT06162585 · Non-Interventional Long Term Follow-up Study of Participants…Ativo
Puerto Rico · 🇺🇸 Estados Unidos
NCT06323772 · Natural History Study in Patients With PDE6A-, PDE6B- and RH…Ativo
🇩🇪 Alemanha
NCT06048185 · Non-interventional Long Term Follow-up Study of Participants…Ativo
🇺🇸 Estados Unidos
NCT07054632 · Efficacy and Safety of LX101 for Inherited Retinal Dystrophy…Ativo
PHASE3🇨🇳 China
NCT06212297 · Fellow-eye Study (FE) of LX101 in Subjects With Inherited Re…Ativo
PHASE1, PHASE2🇨🇳 China
NCT05748873 · Promising ROd-cone DYstrophy Gene therapYAtivo
PHASE1, PHASE2🇫🇷 França · 🇺🇸 Estados Unidos
NCT05573984 · Natural History of PRPF31 Mutation-Associated Retinal Dystro…Ativo
🇦🇺 Austrália · 🇺🇸 Estados Unidos
NCT06196827 · Safety and Tolerability of LX101 for Inherited Retinal Dystr…Ativo
PHASE1🇨🇳 China
NCT04545736 · Oral Metformin for Treatment of ABCA4 RetinopathyAtivo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT04123626 · A Study to Evaluate the Safety and Tolerability of QR-1123 i…Ativo
PHASE1, PHASE2🇺🇸 Estados Unidos
NCT03602820 · Long-term Follow-up Study in Subjects Who Received Voretigen…Ativo
NCT00999609 · Safety and Efficacy Study in Subjects With Leber Congenital …Ativo
PHASE3🇺🇸 Estados Unidos
NCT03359551 · Natural History of the Progression of Choroideremia StudyConcluído
🇧🇷 Brasil · 🇨🇦 Canadá · 🇩🇰 Dinamarca +6
NCT06455826 · MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dyst…Concluído
PHASE1🇺🇸 Estados Unidos
NCT06177977 · SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Ret…Concluído
NA🇺🇸 Estados Unidos
NCT05820100 · Observational Study to Assess the Reliability and Validity o…Concluído
Puerto Rico · 🇺🇸 Estados Unidos
NCT05793515 · Mechanisms of Inherited Retinal Dystrophies Using Whole Geno…Concluído
🇮🇹 Itália
NCT05417126 · Safety and Effects of a Single Intravitreal Injection of vMC…Concluído
PHASE2🇺🇸 Estados Unidos
NCT04945772 · Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults…Concluído
PHASE2Puerto Rico · 🇺🇸 Estados Unidos
NCT04068207 · Minocycline Treatment in Retinitis PigmentosaConcluído
PHASE2🇨🇳 China
NCT04224207 · Management of Retinitis Pigmentosa by Mesenchymal Stem Cells…Concluído
PHASE3Turkey (Türkiye)
NCT03843840 · Dual Wavelength OCTConcluído
🇬🇧 Reino Unido
NCT03592017 · Performance of Long-wavelength Autofluorescence ImagingConcluído
NA🇬🇧 Reino Unido
NCT03613948 · Study on the Effects of Mutations Under Inherited Retinal Di…Concluído
South Korea
NCT00643747 · Safety Study of RPE65 Gene Therapy to Treat Leber Congenital…Concluído
PHASE1, PHASE2🇬🇧 Reino Unido
NCT04855045 · An Open-label, Dose Escalation and Double-masked, Randomized…UNKNOWN
PHASE2, PHASE3🇧🇷 Brasil · 🇧🇪 Bélgica · 🇨🇦 Canadá +4
NCT06224114 · Coloured-light in Retinitis Pigmentosa.UNKNOWN
NA🇬🇧 Reino Unido
NCT04131400 · Establishment of the National Registry for Inherited Retinal…UNKNOWN
Iran
NCT01920867 · Stem Cell Ophthalmology Treatment StudyUNKNOWN
NA🇺🇸 Estados Unidos
NCT03990727 · Phenotype Correlates Genotype of Inherited Retina Dystrophie…UNKNOWN
🇲🇽 México
NCT04658251 · Study of New Mutations in Cone DisordersEncerrado
🇫🇷 França
NCT03561922 · Impact on Daily Life of Patients Using the Subretinal Implan…Encerrado
NA🇫🇷 França
NCT03328130 · Safety and Efficacy Study in Patients With Retinitis Pigment…Encerrado
PHASE1, PHASE2🇫🇷 França
NCT01676766 · Novel Quantification Methods for Fluorescence to Detect Prog…Encerrado
🇺🇸 Estados Unidos
NCT01067742 · The Natural History of Mucolipidosis Type IVEncerrado
🇺🇸 Estados Unidos
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Distrofia da retina, genética.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Distrofia da retina, genética e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

É uma degeneração da retina provocada por alterações herdadas no genoma do paciente. Ela integra uma categoria clínica registrada sob o código ORPHA:71862 e CID-10 H35.5.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

1 publicação do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:71862
    Orphanet
  2. GARD:18916
    GARD (NIH)
  3. Q5811451
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Distrofia da retina, genética. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/distrofia-da-retina-genetica

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Distrofia da retina, genética

ORPHA:71862 · MONDO:0019118
CID-10
H35.5 · Distrofias hereditárias da retina
Ensaios
30 ativos
Medicamentos
8 registrados
UMLS
C0854723
Wikidata

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Moléculas estudadas na doença
fonte: OpenTargets
Rara